GMP Cancer Vaccine Analysis and Qualification

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

GMP-Cancer-Vaccine-Analysis-and-Qualification Cancer vaccines consist of one or more antigenic components, including live-attenuated or killed viral or bacterial particles, proteins, polysaccharides, polynucleotides, and particle conjugates. Additionally, other excipients like adjuvants may be present. Not only the chemical and structural integrity of various components must be maintained, but the immunogenicity must be ensured. Thus, the complexity of vaccines creates a unique challenge for characterization.

As a first-class service producer, Creative Biolabs describes a wide range of analytical technologies for diverse vaccine modalities. These include cancer vaccine identification of physicochemical properties, the purification, and potency testing, and the application of both classical and modern bio-analytical tools. With the help of us, the candidate of cancer vaccines can meet and exceed the GMP requirement quickly and smoothly.

Cancer Vaccine Analysis Services at Creative Biolabs

Today, cancer vaccine is developed either as a prophylactic agent to prevent future infection or as a therapeutic treatment. Here, our vaccine development teams perform a comprehensive suite of methods to evaluate the components of cancer vaccines, including protein (glycoprotein, lipoprotein, etc.), lipid, carbohydrate, and lipopolysaccharide. Specifically, we offer total quality assurance expertise to assist clients' products up to quality with safety and regulatory standards.

Biological Analytical Assays

Biopotency assessment
Biosafety testing
Stability studies
Bulk harvest testing
Cell line safety assessment
cGMP batch release

Clinical trial support
Neutralizing assessment
Protein analysis
Virus validation services
Vector safety assessment
Microbial testing

Physicochemical Analytical Technologies

GMP-Cancer-Vaccine-Analysis-and-Qualification

Chromatography
Electrophoresis
Immunological assays (ELISA, WB, etc.)
Mass spectrometry (MS)
Nuclear magnetic resonance (NMR)
High-performance liquid chromatography (HPLC)
Liquid chromatography-mass spectrometry (LC-MS)
Qualitative PCR (q-PCR)

Highlights from Creative Biolabs

Flexible, versatile analytical techniques for the identification and characterization of cancer vaccines
The deliverable results including detailed design, protocols, report, and interpretation
Seasoned experts and technicians with abundant project experience
Better customized services on pre- and after-sales

Creative Biolabs'teams possess technical expertise in GMP vaccine analytical development and have gained a great reputation in the vaccine industry. We can offer specialized contract services for almost any cancer vaccines to obtain their identity, purity, efficacy, and quantity and provide GMP-compliant process development services.

Furthermore, there is another support for cancer vaccine developments and manufacture studies for stable, efficient, and potent products. If you're interested in related services, please don't hesitate to contact us.

Key Updates

NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER

NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION

NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY

NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION